Evaluating Risks for Vigabatrin Treatment
نویسندگان
چکیده
منابع مشابه
Evaluating software project portfolio risks
Like any other business, software development organizations try to maximize their profits and minimize their risks. Such risks represent the uncertain events and conditions that may prevent enterprises from reaching their goals. This possibility has turned risk management into a major concern, not only for project managers but also for executive officers involved with strategic objectives. In t...
متن کاملTreatment of refractory complex partial seizures: role of vigabatrin
Vigabatrin (VGB) is an antiepileptic drug that was designed to inhibit GABA-transaminase, and increase levels of gamma-amino-butyric acid (GABA), a major inhibitory neurotransmitter in the brain. VGB has demonstrated efficacy as an adjunctive antiepileptic drug for refractory complex partial seizures (CPS) and for infantile spasms (IS). This review focuses on its use for complex partial seizure...
متن کاملVigabatrin versus ACTH in the treatment of infantile spasms.
OBJECTIVE To compare adrenocorticotropic hormone with vigabatrin as a single mono-therapy for infantile spasms. We studied hospitalization time, clinical response, whether complete or partial, time taken for improvement, and presence or absence of recurrence after stopping the medication. Together with improvement of electroencephalographic changes, and time taken for significant response, neur...
متن کاملEvaluating treatment for obesity
by Richard T. Lindsey, Ph.D. ad the incidence rates of adult obesity resting between 15 percent and 50 percent (Bray, 1976) and with 25 percent of American youth being obese, an important challenge presents itself for practitioners of health care. In sheer numbers these statistics represent approximately 34 million people (Van Itallie, 1985). Not only do the obese bear the brunt of social ridic...
متن کاملLong-term treatment with vigabatrin – 10 years of clinical experience
This report describes the long-term follow-up of 56 patients with refractory partial epilepsy who, within 3 months of vigabatrin add-on therapy (3 g/day), showed a reduction in monthly seizure frequency of more than 50%. The short-term (6 months) and long-term (5 years) effects of vigabatrin on seizure frequency in this patient cohort have been published separately. The reduction in seizure fre...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Epilepsy Currents
سال: 2009
ISSN: 1535-7597,1535-7511
DOI: 10.1111/j.1535-7511.2009.01315.x